80 related articles for article (PubMed ID: 28540167)
1. The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages.
Wu Z; Zhao X; Li R; Wen X; Xiu Y; Long M; Li J; Huang X; Wen J; Dong X; Xu Y; Bai Z; Zhan X; Xiao X
Chin Med; 2024 Mar; 19(1):48. PubMed ID: 38500179
[TBL] [Abstract][Full Text] [Related]
2. A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA.
Zeng Z; Han S; Hong W; Lang Y; Li F; Liu Y; Li Z; Wu Y; Li W; Zhang X; Cao Z
Mol Ther Nucleic Acids; 2016 Mar; 5(3):e295. PubMed ID: 26978579
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis.
Shi H; Chen D; Si J; Zou Q; Guo Y; Yu J; Li C; Wang F
Dermatol Ther (Heidelb); 2024 Jun; 14(6):1659-1670. PubMed ID: 38796792
[TBL] [Abstract][Full Text] [Related]
4. Oxymatrine Modulation of TLR3 Signaling: A Dual-Action Mechanism for H9N2 Avian Influenza Virus Defense and Immune Regulation.
Zhi Y; Zhao X; Liu Z; Shen G; Zhang T; Zhang T; Hu G
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731436
[TBL] [Abstract][Full Text] [Related]
5. The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges.
Ge F; Yang Y; Bai Z; Si L; Wang X; Yu J; Xiao X; Liu Y; Ren Z
Chin Med; 2023 Dec; 18(1):159. PubMed ID: 38042824
[TBL] [Abstract][Full Text] [Related]
6. Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and
Cao X; Zhang N; Chen H; Wang W; Liang Y; Zhang J; Liu R; Li S; Yao Y; Jin Q; Guo Z; Chen Y; Gong Y; Li X; Zao X; Ye Y
Front Pharmacol; 2023; 14():1159094. PubMed ID: 37361218
[TBL] [Abstract][Full Text] [Related]
7. The progress of molecules and strategies for the treatment of HBV infection.
Pan Y; Xia H; He Y; Zeng S; Shen Z; Huang W
Front Cell Infect Microbiol; 2023; 13():1128807. PubMed ID: 37009498
[TBL] [Abstract][Full Text] [Related]
8. Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines.
Sandenon Seteyen AL; Girard-Valenciennes E; Septembre-Malaterre A; Gasque P; Guiraud P; Sélambarom J
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014321
[TBL] [Abstract][Full Text] [Related]
9. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV)
Ge FL; Si LL; Yang Y; Li YH; Lv ZL; Liu WH; Liao H; Wang J; Zou J; Li L; Li H; Zhang ZL; Wang JB; Lu XC; Xu DP; Bai ZF; Liu Y; Xiao XH
Front Pharmacol; 2021; 12():756975. PubMed ID: 34776974
[TBL] [Abstract][Full Text] [Related]
10. Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments.
Wang H; Ding Y; Zhang W; Wei K; Pei Y; Zou C; Zhang C; Ding J; Fang H; Tan S
Drug Des Devel Ther; 2020; 14():921-931. PubMed ID: 32184561
[TBL] [Abstract][Full Text] [Related]
11. Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis.
Wang Y; Zhang J; Jin Y; Xiao X; Zhang Q
Medicine (Baltimore); 2020 Jan; 99(5):e18898. PubMed ID: 32000393
[TBL] [Abstract][Full Text] [Related]
12. Combination of oxymatrine and diammonium glycyrrhizinate significantly mitigates mice allergic contact dermatitis induced by dinitrofluorobenzene.
Shi HJ; Song HB; Gao Q; Si JW; Zou Q
Exp Biol Med (Maywood); 2019 Oct; 244(13):1111-1119. PubMed ID: 31342769
[TBL] [Abstract][Full Text] [Related]
13. SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade.
Zhao M; Guo W; Wu Y; Yang C; Zhong L; Deng G; Zhu Y; Liu W; Gu Y; Lu Y; Kong L; Meng X; Xu Q; Sun Y
Acta Pharm Sin B; 2019 Mar; 9(2):304-315. PubMed ID: 30972278
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8
Ye J; Zou MM; Li P; Lin XJ; Jiang QW; Yang Y; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Shi Z; Liu H
Front Oncol; 2018; 8():631. PubMed ID: 30619765
[TBL] [Abstract][Full Text] [Related]
15. T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.
Sang X; Wang R; Han Y; Zhang C; Shen H; Yang Z; Xiong Y; Liu H; Liu S; Li R; Yang R; Wang J; Wang X; Bai Z; Xiao X
Acta Pharm Sin B; 2017 May; 7(3):311-318. PubMed ID: 28540167
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Serum IFN- and IL-5 Levels in Response to Entecavir Therapy in Patients with Chronic Hepatitis B Virus Infection.
Badary TM; ElBadawy O; Agban MN; Kamel S; Sadek A
Egypt J Immunol; 2018 Jan; 25(1):93-103. PubMed ID: 30243001
[TBL] [Abstract][Full Text] [Related]
17. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
18. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
